Publications (48)

2023

  1. Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice

    Antibiotics, Vol. 12, Núm. 3

  2. Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection

    The Pediatric infectious disease journal, Vol. 42, Núm. 8, pp. e290-e292

2021

  1. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid

    International Journal of Antimicrobial Agents, Vol. 57, Núm. 2

  2. Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain

    Expert Review of Clinical Pharmacology, Vol. 14, Núm. 2, pp. 249-260

  3. Correction to: Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety (Drugs in R&D, (2021), 21, 1, (39-64), 10.1007/s40268-020-00329-w)

    Drugs in R and D

  4. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety

    Drugs in R and D, Vol. 21, Núm. 1, pp. 39-64

2020

  1. Standardization for safety: A feasible challenge

    Farmacia Hospitalaria

2019

  1. Variability in management and outcomes of therapy with eculizumab in atypical hemolytic uremic syndrome

    Expert Opinion on Orphan Drugs, Vol. 7, Núm. 12, pp. 525-533

2018

  1. Estudio comparativo de contaminación de tres sistemas cerrados para la preparación de fármacos peligrosos mediante simulación con fluoresceína

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 42, Núm. 6, pp. 234-238

2017

  1. Downbeat nystagmus due to ranitidine in a pediatric patient

    European Journal of Paediatric Neurology, Vol. 21, Núm. 4, pp. 682-684

  2. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

  3. Utilización de medicamentos en condiciones off-label y unlicensed: resultados de un estudio piloto realizado en una unidad de cuidados intensivos pediátricos

    Anales de Pediatria, Vol. 86, Núm. 1, pp. 28-36

2016

  1. Administración segura de medicamentos intravenosos en pediatría: 5 años de experiencia de una Unidad de Cuidados Intensivos Pediátricos con bombas de infusión inteligentes

    Medicina Intensiva, Vol. 40, Núm. 7, pp. 411-421

  2. Antiinfecciosos vía general

    Medimecum 2016: guía de terapia farmacológica ([Madrid] : Springer), pp. 559-728

  3. Clinical guidelines for infantile-onset Pompe disease

    Revista de neurologia, Vol. 63, Núm. 6, pp. 269-279

  4. Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

    Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 901-908

  5. Individualized therapy in patients with Fabry disease: is it a feasible strategy for rare diseases?

    Expert Opinion on Orphan Drugs, Vol. 4, Núm. 12, pp. 1199-1206

  6. Ivermectina subcutánea en estrongiloidiasis diseminada: a propósito de la autorización de un medicamento veterinario para uso humano

    Medicina Clinica

  7. Palatability assessment of oral liquid compounding products in a tertiary pediatric hospital

    Latin American Journal of Pharmacy, Vol. 35, pp. 1234-1240

  8. Unidad de Farmacia Materno- Infantil. Servicio de Farmacia del Hospital General Universitario Gregorio Marañón

    Revista española de pediatría: clínica e investigación, Vol. 72, Núm. 6, pp. 381-386